← FDA DRUG APPROVALS
FDA ANDA · ANDA213466
FEXOFENADINE HYDROCHLORIDE
fexofenadine hydrochloride oral
Sponsor: AUROBINDO PHARMA LTD
APPLICATION
ANDA213466
TYPE
ANDA
ORIGINAL APPROVAL
2023-05-23
LATEST ACTION
2023-05-23
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Over-the-counter
Products
FEXOFENADINE HYDROCHLORIDEOver-the-counter
FEXOFENADINE HYDROCHLORIDE 30MG/5ML · SUSPENSION · ORAL
Approval history
2023-05-23UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.